• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-17 在大疱性类天疱疮发病机制中的潜在作用。

Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.

机构信息

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.

出版信息

Med Hypotheses. 2010 Apr;74(4):727-8. doi: 10.1016/j.mehy.2009.10.038. Epub 2009 Nov 28.

DOI:10.1016/j.mehy.2009.10.038
PMID:19945799
Abstract

Bullous pemphigoid is an autoimmune blistering disease of the skin caused by autoantibodies directed against basement membrane zone adhesion molecules. Autoantibodies cannot fully explain several important features of the disease such as the difficulty transferring with the pathogenic autoantibodies, or the presence of heavy lesional infiltration of eosinophils and neutrophils that is necessary for disease production. There is increasing evidence that Th17 cells and the cytokines they release such as interleukin-17 are important regulators of innate and adaptive immune responses in many Th1 and/or Th2 mediated autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and allergic asthma. There is also evidence that Th17 cells have a role in pathogenesis of blistering skin diseases. Interleukin-17 is important in initiation and maintenance of many autoimmune reactions and it is involved in production of pro-inflammatory cytokines, matrix metalloproteinases, neutrophils, and eosinophils, all of which are important pathogenic factors in bullous pemphigoid. The hypothesis is that interleukin-17 has an important pathogenic role in BP and can describe features of the disease not explained by the autoantibody theory. This cytokine can be assessed in the blister fluid and sera of patients, and can be used as a marker of disease activity and response to therapy. The information obtained could also lead to the development of novel therapeutic strategies for this and other autoimmune blistering diseases.

摘要

大疱性类天疱疮是一种自身免疫性水疱病,由针对基底膜带黏附分子的自身抗体引起。自身抗体不能完全解释该疾病的几个重要特征,例如难以与致病性自身抗体转移,或病变部位浸润大量嗜酸性粒细胞和中性粒细胞,而这些细胞对于疾病的发生是必需的。越来越多的证据表明,Th17 细胞及其释放的细胞因子,如白细胞介素-17,是许多 Th1 和/或 Th2 介导的自身免疫性疾病(如类风湿关节炎、系统性红斑狼疮和过敏性哮喘)中固有和适应性免疫反应的重要调节剂。也有证据表明,Th17 细胞在水疱性皮肤病的发病机制中起作用。白细胞介素-17 在许多自身免疫反应的启动和维持中起着重要作用,它参与促炎细胞因子、基质金属蛋白酶、中性粒细胞和嗜酸性粒细胞的产生,所有这些都是大疱性类天疱疮的重要致病因素。假设白细胞介素-17 在 BP 中具有重要的致病作用,可以描述自身抗体理论无法解释的疾病特征。这种细胞因子可以在患者的水疱液和血清中进行评估,并可用作疾病活动和治疗反应的标志物。所获得的信息还可能为这种疾病和其他自身免疫性水疱病的治疗策略的发展提供依据。

相似文献

1
Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.白细胞介素-17 在大疱性类天疱疮发病机制中的潜在作用。
Med Hypotheses. 2010 Apr;74(4):727-8. doi: 10.1016/j.mehy.2009.10.038. Epub 2009 Nov 28.
2
Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation.大疱性类天疱疮:白细胞介素5、抗基底膜带抗体与嗜酸性粒细胞的相互作用。一项初步观察。
Cytokine. 2001 Jan 7;13(1):32-38. doi: 10.1006/cyto.2000.0791.
3
Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.大疱性类天疱疮和线状IgA大疱性皮病患者对BP180表现出IgA和IgG双重自身免疫反应。
J Autoimmun. 2000 Nov;15(3):293-300. doi: 10.1006/jaut.2000.0437.
4
Histopathology of anti-p200 pemphigoid.抗p200类天疱疮的组织病理学
Am J Dermatopathol. 2007 Apr;29(2):119-24. doi: 10.1097/DAD.0b013e31803326e6.
5
Bullous pemphigoid and related subepidermal autoimmune blistering diseases.大疱性类天疱疮及相关的表皮下自身免疫性大疱病
Curr Dir Autoimmun. 2008;10:141-66. doi: 10.1159/000131452.
6
Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.针对人胶原蛋白 17 非胶原 16A 结构域的人 IgG1 单克隆抗体通过补体激活在实验性大疱性类天疱疮模型中诱导水疱。
J Immunol. 2010 Dec 15;185(12):7746-55. doi: 10.4049/jimmunol.1000667. Epub 2010 Nov 12.
7
A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.一名儿童体内存在同时靶向线状IgA大疱性皮肤病和大疱性类天疱疮抗原的抗体。
Arch Dermatol. 1995 Dec;131(12):1438-42.
8
Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.免疫损伤机制。天疱疮和大疱性类天疱疮。
Arch Dermatol. 1983 Sep;119(9):711-4.
9
[Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].[类天疱疮患者皮肤中的免疫现象与病理过程的关系]
Przegl Dermatol. 1988 Jul-Aug;75(4):266-71.
10
The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.非大疱性红斑狼疮患者血清中抗基底膜带抗体的存在。
Br J Dermatol. 1997 Feb;136(2):222-6.

引用本文的文献

1
A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects.白细胞介素-17抑制剂在大疱性类天疱疮中的作用的系统评价:治疗作用与矛盾效应
Arch Dermatol Res. 2025 Mar 11;317(1):544. doi: 10.1007/s00403-025-04052-x.
2
Case report: Bullous pemphigoid combined with Sjögren's syndrome complicated by central nervous system infection.病例报告:大疱性类天疱疮合并干燥综合征并发中枢神经系统感染。
Front Immunol. 2024 Sep 10;15:1419054. doi: 10.3389/fimmu.2024.1419054. eCollection 2024.
3
Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.
推进大疱性类天疱疮的治疗:新型治疗靶点和方法的全面综述。
Clin Rev Allergy Immunol. 2023 Dec;65(3):331-353. doi: 10.1007/s12016-023-08973-1. Epub 2023 Oct 28.
4
Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy.病例报告:大疱性类天疱疮与银屑病共存:治疗挑战及以白细胞介素17A为靶点的并行治疗策略
Front Med (Lausanne). 2023 Apr 3;10:1148660. doi: 10.3389/fmed.2023.1148660. eCollection 2023.
5
Bullous pemphigoid caused by contact allergy to bone cement: A case report.骨水泥接触过敏引起的大疱性类天疱疮:一例报告。
Contact Dermatitis. 2021 Jun;84(6):457-458. doi: 10.1111/cod.13757. Epub 2020 Dec 27.
6
Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris.寻常型天疱疮中JAK3、STAT2、STAT4和STAT6的表达
Immunol Res. 2020 Apr;68(2):97-103. doi: 10.1007/s12026-020-09122-y.
7
Current Clinical Trials in Pemphigus and Pemphigoid.天疱疮和类天疱疮的当前临床试验。
Front Immunol. 2019 May 3;10:978. doi: 10.3389/fimmu.2019.00978. eCollection 2019.
8
Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.JAK/STAT 信号通路在大疱性类天疱疮和疱疹样皮炎中的表达。
Mediators Inflamm. 2017;2017:6716419. doi: 10.1155/2017/6716419. Epub 2017 Oct 24.
9
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.整合纵向血清白细胞介素-17和白细胞介素-23随访结果以及自身抗体变化,有助于预测大疱性类天疱疮的预后。
Sci Rep. 2015 Dec 14;5:18001. doi: 10.1038/srep18001.
10
Response of peripheral blood Th17 cells to inhaled Dermatophagoides pteronyssinus in patients with allergic rhinitis and asthma.变应性鼻炎和哮喘患者外周血 Th17 细胞对吸入性屋尘螨的反应。
Lung. 2012 Oct;190(5):487-95. doi: 10.1007/s00408-012-9411-y. Epub 2012 Jul 28.